Martin Shkrell continues his business from prison

Martin Shkrell is continuing to lead his pharmaceutical company from prison through a mobile phone that has been smuggled into his cell.

So publishes CNN for the former executive chief of a medical medicine company that received the first titles of international media to raise the price of a drug before being found guilty of defrauding investors. The stock raised the Darapim price used by AIDS patients from $13.5 to $750. This caused the Albanian to become the most hated man in the world.

According to CNN, Shkrely is leading from Phoenix AG prison, formerly known as Touring Pharmacologicals and believes this company will become even more successful while he is in prison. He thinks the company he owns 40% of the shares will be worth $3.7 billion when he gets out of jail.

In the last call he made, it's learned that Shkrely fired CEO Kevin Mullady. Then he changed his mind and simply suspended it. / TCh/